Dr. Allen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1365 Clifton Rd NE
Atlanta, GA 30322Phone+1 404-778-1900Fax+1 404-778-3002- Is this information wrong?
Summary
- Dr. Pamela Allen is a hematologist in Atlanta, GA and is affiliated with multiple hospitals in the area, including Emory University Hospital and Emory University Hospital Midtown. She received her medical degree from University of Florida College of Medicine and has been in practice 7 years. She specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and hodgkin's lymphoma.
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2014 - 2017
University of MarylandResidency, Internal Medicine, 2010 - 2013
University of Florida College of MedicineClass of 2010
Certifications & Licensure
GA State Medical License 2017 - 2024
IL State Medical License 2014 - 2017
FL State Medical License 2013 - 2015
WV State Medical License 2013 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Mogamulizumab and Extracorporeal Photopheresis for the Treatment of Sezary Syndrome or Mycosis Fungoides Start of enrollment: 2021 Apr 21
Publications & Presentations
PubMed
- 4 citationsSequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma.Pamela B Allen, Xinyan Lu, Qing Chen, Kaitlyn O'Shea, Joan S Chmiel, Liron Barnea Slonim, Madina Sukhanova, Hatice Savas, Andrew M Evens, Ranjana Advani, Barbara Pro, ...> ;Blood Advances. 2023 Jun 27
- Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies.Andres Chang, Jean L Koff, Lilin Lai, Victor M Orellana-Noia, Minal Surati, Alyssa M K Leal, Madison L Ellis, Bushra Wali, Alberto Moreno, Susanne L Linderman, Colin B...> ;Blood Advances. 2023 Jun 13
- 1 citationsCharacterizing Outcomes in Visceral Cutaneous T-Cell Lymphoma: A Single Center Retrospective Study.Tony Zibo Zhuang, Ashley McCook-Veal, Jeffrey Switchenko, Tim Niyogusaba, Erica S Tarabadkar, Katelin Baird, Colin O'Leary, Darina Paulino, Mary Jo Lechowicz, Pamela B...> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Sep 1
- Join now to see all
Abstracts/Posters
- Safety and Toxicity Profile of Pembrolizumab (PEM) in Combination with ICE Chemotherapy Followed By Autologous Stem Cell Transplantation for Relapsed/Refractory Classi...Pamela Allen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- North American Practice Patterns for PET-2 Positive Hodgkin LymphomaPamela Allen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Mortality and Risk Factors for Bacteremia in Patients with Cutaneous T-Cell Lymphoma (CTCL) at Emory UniversityPamela Allen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Press Mentions
Dr. Allen on Treatment Options in Advanced-Stage Hodgkin LymphomaJanuary 13th, 2020
The Evolution of Frontline Hodgkin Lymphoma TreatmentJune 13th, 2019
Professional Memberships
- Member
- Member
Hospital Affiliations
Emory University HospitalAtlanta, Georgia
Emory University Hospital MidtownAtlanta, Georgia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
